Page results
-
Penile cancer is a rare malignancy. Just over 700 men are diagnosed with penile cancer in the UK each year. It is most common in men over the age of 50, although younger men are also at risk. There…
-
UCLH is making a commitment to reduce its impact on the environment with a 10-point plan to reach net zero carbon dioxide emissions in 10 years.
-
UCLH is one of only twelve specialist centres in the UK for the treatment of penile cancer, and one of only two in London. UCLH provides a comprehensive penile cancer service for patients, together…
-
We provide routine histopathological diagnoses using both standard techniques and advanced diagnostics including immunocytochemistry, fluoresent in-situ hybridisation (FISH), and polymerase chain…
-
This page offers ways you can help us to prevent infection and make your babies safer.
-
Overall, most women (over 90%) spontaneously give birth to their baby after 37 weeks of pregnancy, called term delivery. Approximately 10%, or 1 in 10 women spontaneously give birth to their baby…
File results
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
-
FOI/2022/0230 - Fabry, Gaucher and Pompe diseases drug treatments
-
FOI/2022/0232 - Number of patients who have died while waiting for elective care
-
FOI/2022/0233 - Diagnosis/ treatment of epilepsy, dravet syndrome, lennox gastaut syndrome and tuberous sclerosis complex